Results 101 to 110 of about 10,740,045 (356)

Incidence of COVID‐19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?

Arthritis & Rheumatology, 2020
To describe the incidence and severity of coronavirus disease 2019 (COVID‐19) in patients with rheumatic diseases treated with targeted synthetic or biologic disease‐modifying antirheumatic drugs (DMARDs) compared with that in the general population ...
E. Favalli, S. Monti, F. Ingegnoli, S. Balduzzi, R. Caporali, C. Montecucco   +5 more
semanticscholar   +1 more source

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development

Arthritis Care &Research, EarlyView.
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg, Izzy Hartel, Lisa R. Sammaritano, Anca Askanase, Bonnie L. Bermas, Maria Dall'Era, Alí Duarte‐García, Victoria P. Werth, Brad Rovin, Reem A. Mustafa, Amy S. Turner, Bené Williams, Brian L. Ung, Hiya Bhavsar, Monique C. Gore‐Massy, Nahirannette Pulido, Natacha Guerrero, Natalie M. Smith, Wambui Machua, Linda T. Hiraki, Mary Beth Son   +20 more
wiley   +1 more source

Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study

BMJ Open, 2019
IntroductionRheumatoid arthritis (RA) and ankylosing spondylitis (AS) are chronic, systemic, inflammatory diseases, primarily in the musculoskeletal system. Pain and fatigue are key symptoms of RA and AS.
Afshin Ashouri Christiansen, Ellen Margrethe Hauge, Tina Ingrid Horsted, Anja Godske Bachmann, Anders Bo Bojesen, Kirsten Kaya Roessler, Kim Hørslev Petersen   +6 more
doaj   +1 more source

Reliability exercise for the polymyalgia rheumatica classification criteria study : the Oranjewoud ultrasound substudy [PDF]

, 2009
Objective. A study supported by the EULAR and the ACR being conducted to establish classification criteria for polymyalgia rheumatica (PMR) will include ultrasound examination of the shoulders and hips. Ultrasound (US) depicts glenohumeral joint effusion,
Bruyn, George A. W., Dasgupta, Bhaskar, Matteson, Eric L., Ohrndorf, Sarah, Scheel, Alexander Konrad, Schmidt, Wolfgang Andreas, Werner, Carola   +6 more
core   +2 more sources

What is the true incidence of COVID-19 in patients with rheumatic diseases?

Annals of the Rheumatic Diseases, 2020
After its emergence in December 2019 in Wuhan, China, the COVID-19 outbreak has now one of its main epicentres in Lombardy (Italy), with more than 50 000 confirmed cases and 9000 deaths.
E. Favalli, F. Ingegnoli, R. Cimaz, R. Caporali   +3 more
semanticscholar   +1 more source

Validation of a Genetic Risk Score Combined With Clinical Variables for Predicting Pulmonary Fibrosis in Early Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective Pulmonary fibrosis (PF) is a severe extra‐articular manifestation of rheumatoid arthritis (RA). This study aimed to externally validate a genetic risk score (GRS) and a combined risk score (CRS) for predicting the risk of RA‐associated PF in an independent cohort of patients with early RA.
Mikael Brink, Austin Wheeler, Bryant R. England, Solbritt Rantapää‐Dahlqvist   +3 more
wiley   +1 more source

Clinical and Serological Findings of Patients with Antiphospholipid Syndrome in Mashhad, Iran, from 2008 to 2018: A Retrospective, Descriptive, Cross-sectional Study

European Journal of Rheumatology
Objective: Antiphospholipid syndrome (APS) is among the autoimmune disorders caused by antiphospholipid antibodies, which provoke blood clots (thrombosis) in arteries and veins.
Zahra Rezaieyazdi, Maryam Sahebari, Kianoosh Shahideh, Muhammed Joghatayi, Mandana Khodashahi   +4 more
doaj   +1 more source

The prevalence of rheumatic diseases in the elderly in developed countries and its evolution over time [PDF]

, 2018
Summary.: Objectives: This study aims at evaluating the prevalence of rheumatic diseases in the elderly and its evolution over time. Methods: We present a systematic international literature review of the prevalence of rheumatic diseases in the elderly ...
Mariller, Marjorie, Santos-Eggimann, Brigitte   +1 more
core  

Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern. The fragile balance between infections and autoimmunity [PDF]

, 2020
On 7 January 2020, researchers isolated and sequenced in China from patients with severe pneumonitis a novel coronavirus, then called SARS-CoV-2, which rapidly spread worldwide, becoming a global health emergency.
Diamanti, A. P., Lagana, B., Pioli, C., Rosado, M. M., Sesti, G.   +4 more
core   +2 more sources

Glycosylation and rheumatic disease

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1998
Rheumatoid arthritis (RA) and other rheumatic diseases are associated with a significant defect in the galactosyltransferase enzyme that results in a profound change in the galactosylation of immunoglobulin G. This change has been demonstrated to be integrally associated with pathogenic mechanisms associated with inflammation in RA.
openaire   +3 more sources